Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease

American Journal of Clinical Nutrition

Volumn 63, Issue 3, 1996, Pages 377-385

  Regnström, Jan ^a   Nilsson, Jan ^b   Moldeus, Peter ^b   Ström, Kerstin ^b   Båvenholm, Peter ^b   Tornvall, Per ^b   Hamsten, Anders ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Coronary artery disease; lipid peroxidation; low density lipoprotein; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; HUMAN; LIPID ANALYSIS; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATION; PROTEIN ANALYSIS;

EID: 0029866941     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/63.3.377     Document Type: Article

References (68)

1. Keys A. Seven countries: death and coronary heart disease. Cambridge, MA: Harvard University Press, 1980.
2. Hopkins PN, Williams RR. A survey of 246 suggested coronary risk factors. Atherosclerosis 1981:40:1-52.
3. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53(suppl):326S-34S.
4. Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991;337:1-5.
5. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett W. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
6. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9.
7. Salonen JT, Salonen R, Penttilä I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 1985;56:226-31.
8. Kok F, de Bruijn A, Vermeeren R, et al. Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987;45:462-8.
9. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-25.
10. Palinsky W, Rosenfeld ME, Ylä-Herttuala, et al. Low density lipoprotein undergoes modification in vivo. Proc Natl Acad Sci USA 1989;86:1372-6.
11. Yla-Herttuala S, Palinsky W, Rosenfeld ME, et al. Evidence for presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-95.
12. Wiztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-92.
13. Hansson GK, Jonasson L, Seifert PS, Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis 1989;9:567-78.
14. Frostegård J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T cell activation by oxidized low density lipoprotein. Arterioscler Thromb 1992;12:461-7.
15. Stringer MD, Gorög PG, Freeman A, Kakkar VV. Lipid peroxides and atherosclerosis. Br Med J 1989;298:281-4.
16. Liu K, Cuddy TE, Pierce GN. Oxidative status of lipoproteins in coronary disease patients. Am Heart J 1992;123:285-90.
17. Salonen JT, Ylä-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339:883-7.
18. Regnström J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992;339:1183-6.
19. Tornvall P, Båvenholm P, Landou C, de Faire U, Hamsten A. Relationship of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 1993; 88:2180-9.
20. Carlson K. Lipoprotein fractionation. J Clin Pathol 1973;5:32-7.
21. Hamsten A, Walldius G, Dahlen G, Johansson B, De Faire U. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis 1986;59:223-35.
22. Redgrave TG, Roberts DCK, West CE. Separation of plasma lipoproteins by density gradient ultracentrifugarion. Anal Biochem 1975;65: 42-9.
23. Tornvall P, Karpe F, Carlson LA, Hamsten A. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 1991;90:67-80.
24. Lowry O, Rosenbrough N, Farr A, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
25. Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem 1986;157:106-16.
26. Chou PP, Jaynes PK, Balley JL Determination of vitamin E in microsamples of serum by liquid chromatography with electrochemical detection. Clin Chem 1985;31:880-2.
27. Esterbauer H, Striegl G, Puhl H, Rothender M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
28. Hamsten A, Walldius G, Szamosi A, Dahlen G, de Faire U. Relationship of angiographically defined coronary artery disease to serum lipoproteins in young survivors of myocardial infarction. Circulation 1986;73:1097-110.
29. Gensini GG. Coronary arteriography. Mount Kisco, NY: Futura Publishing Co, 1975.
30. McGill D, Talsma P, Ardlie N. Relationship of blood cholesterol and apoprotein B levels to angiographically defined coronary artery disease in young males. Coronary Artery Dis 1993;4:261-70.
31. Austen WG, Edwards JE, Frye RL, et al. AHA Committee Report: a reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease. Council on Cardiovascular Surgery. American Heart Association. ASCA Committee Report. Circulation 1975;52:5-40.
32. Snedecor GW, Cochran WG. Statistical methods. Ames, IA: Iowa State University Press, 1978
33. Jessup W, Rankin SM, de Whalley CV, Hoult JRS, Scott J, Leake DS. Alpha-tocopherol consumption during low-density-lipoprotein oxidation. Biochem J 1990;265:399-405.
34. Baiby AV, Gebicki JM, Sullivan DR. Vitamin E content and low density lipoprotein oxidizability induced by free radicals. Atherosclerosis 1990;81:175-82.
35. Cominacini L, Garbin U, Cenci B, et al. Predisposition to LDL oxidation during copper-catalyzed oxidative modification and its relation to alpha-tocopherol content in humans. Clin Chim Acta 1991;204: 57-68.
36. de Graaf J, Hak-Lemmers H, Hectors M, Demacker P, Hendriks J, Stalenhoef A. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991;11:298-306.
37. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992;93:189-99.
38. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and the resistance to oxidation. J Lipid Res 1991;32:1325-32.
39. Jialal I, Grundy SM. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 1992;33:899-906.
40. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by β-carotene. Arterioscler Thromb 1993;13:712-9.
41. Reaven PD, Witztum JL. Comparison of supplementation of RRR-α-tocopherol and racemic α-tocopherol in humans. Effects on lipid levels and lipoprotein susceptibility to oxidation. Arterioscler Thromb 1993; 13:601-8.
42. Belcher JD, Balla J, Jacobs DR, Gross M, Jacob HS, Vercellotti GM. Vitamin E, LDL and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler Thromb 1993;13:1779-89.
43. Jialal I, Fuller CJ, Huet BA. The effect of α-tocopherol supplementation on LDL oxidation. A dose-response study. Proc Natl Acad Sci U S A 1994;94:1183-7.
44. de Graaf J, Hendriks J, Demacker P, Stalenhoef A. Identification of multiple dense LDL subfractions with enhanced susceptibility to in-vivo oxidation among hypertriglyceridemic individuals. Normalization after clofibrate treatment. Arterioscler Thromb 1993;13:712-9.
45. Kleinveld H, Naber A, Stalenhoef A, Demacker P. Oxidation resistance, oxidation rate, and extent of oxidation in human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects. Free Radic Biol Med 1993;15:273-80.
46. Kontush A, Hübner C, Finkh B, Kohlschütter A, Beisiegel U. Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol-10 and polyunsaturated fatty acid content. FEBS Lett 1994; 341:69-73.
47. Tribble D, Van den Berg J, Motchnik P, et al. Oxidative susceptibilty of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content. Proc Natl Acad Sci U S A 1994:1183-7.
48. Thomas M, Thornburg T, Manning J, Hooper K, Rudel L. Fatty acid composition of low-density lipoprotein influences its susceptibilty to autooxidation. Biochemistry 1994;33:1828-34.
49. de Rijke Y, Vogelzang C, van Berkel T, et al. Susceptibility of low-density lipoproteins to oxidation in coronary bypass patients. Lancet 1992;340:858-9.
50. Cominacini L, Garbin U, Pastorino A, et al. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis 1993;99:63-70.
51. Andrews B, Burnand K, Paganga G, et al. Oxidisability of low density lipoproteins in patients with carotid or femoral atherosclerosis. Atherosclerosis 1995;112:77-84.
52. Davies MJ, Wolfe N, Robertson WB. Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. Br Heart J 1976;38:659-64.
53. Dewood MA, Spores J, Notske RN. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction N Engl J Med 1980;303:897-902.
54. Falk E. Plaque rupture with severe preexisting stenosis precipitating coronary thrombosis characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983;50:127-34.
55. Fuster V, Badimon L, Badimon JJ, Chesebro JH The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
56. Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation 1989;80:1747-56.
57. Arbustini E, Grasso M, Diegoli M, et al. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphological, immunohistochemical and biochemical study. Am J Cardiol 1991;68:36B-50B.
58. Traber MG, Kayden HJ. Vitamin E is delivered to cells via the high affinity receptor for low-density lipoprotein. Am J Clin Nutr 1984;40: 747-51.
59. Traber MG, Olivercrona T, Kayden HJ. Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro. J Clin Invest 1985;75:1729-34.
60. Negre-Salvayre A, Alomar Y, Troly M, Salvayre R. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effects of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways. Biochim Biophys Acta 1991;1096:291-300.
61. Mezzetti A, Lapenna D, Pierdomenico S, et al. Vitamin E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Atherosclerosis 1995;112:91-9.
62. Boscoboinik D, Szewczyk A, Hensey C, Azzi A. Inhibition of cell proliferation by alpha-tocopherol. J Biol Chem 1991;266: 6188-94.
63. Akeson AL, Woods CW, Mosher LB, Thomas CE, Jackson RL. Inhibition of IL-1β expression in THP-1 cells by probucol and tocopherol. Atherosclerosis 1992;86:261-70.
64. Steiner M. Influence of vitamin E on platelet function in humans. J Am Coll Nutr 1991;10:466-73.
65. Horwitt M, Harvey C, Dahm C, Searcy M. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann N Y Acad Sci 1972;203:223-36.
66. Bjornson LK, Kayden HJ, Miller E, Moshell AN. The transport of α-tocopherol and β-carotene in human blood. J Lipid Res 1976;17: 343-52.
67. Lambert D, Mourot J. Vitamin E and lipoproteins in hyperlipoproteinemia. Atherosclerosis 1984;53:327-30.
68. Bolton-Smith C, Woodward M, Tunstall-Pedoe H. The Scottish heart health study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. II. The antioxidant vitamins and fibre. Eur J Clin Nutr 1992;46:85-93.